XLIM
INR
Market cap3.91bUSD
May 29, Last price
30.71USD
Name
InRetail Peru Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
InRetail Perú Corp., together with its affiliated entities, functions as a diverse retail enterprise predominantly operating within Peru. The company's extensive business activities are structured across five distinct divisions: The Food Retail division oversees a range of grocery outlets, including supermarkets, hypermarkets, discount stores, and cash-and-carry formats. Its Pharmacies segment is responsible for the provision of pharmaceuticals, medical supplies, and cosmetic products through its well-known Inkafarma and Mifarma pharmacy chains. The Distribution division manages the supply chain for drugs, medicines, and various consumer goods. The Shopping Center segment focuses on the leasing of commercial premises situated within its portfolio of shopping complexes. Lastly, the Digital segment is dedicated to the management, operation, and support of its digital commerce platforms and services. In addition to its core retail operations, the corporation also participates in real estate development initiatives. Founded in 2011, InRetail Perú Corp. is headquartered in Lima, Peru, and operates as a subsidiary of Intercorp Retail Inc.
Key people
Chief Financial Officer · since 2016
Jorge Lazarte
Corporate Legal Affairs Vice President
Arevalo Flores Jorge Gilberto
General Accountant
Director · since 2015
Director · since 2018
Luis Carranza Ugarte
Independent Director · since 2015
Mariela Garcia Figari
Independent Director · since 2019
Ignacio Benito Marchese
Independent Director · since 2019
Legal address
C/O Arias, Aleman & Mora
Calles 50 y 74
Edificio PH 909, Piso 16
Ciudad de Panama, 8 0830
PA
Calles 50 y 74
Edificio PH 909, Piso 16
Ciudad de Panama, 8 0830
PA
Headquarters
Calle Morelli 139
Piso 5
San Borja
Lima, LIM 15021
PE
Piso 5
San Borja
Lima, LIM 15021
PE
Valuation
Title PEN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||